As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: September 5, 2012
by Personal Liberty Digest:
A group of researchers say they have developed research recommendations to determine why nearly two-thirds of U.S. adults with Alzheimer’s disease are women.
The recommendations, published in a Roundtable discussion in Journal of Women’s Health, were created by an interdisciplinary roundtable of experts convened by the Society for Women’s Health Research in Washington to guide future Alzheimer’s disease research.
Dr. Susan G. Kornstein, editor in chief of Journal of Women’s Health and executive director of the Virginia Commonwealth University Institute for Women’s Health in Richmond, Va., said the recommendations make the evaluation of sex and gender differences a component of future studies.
“There are still major gaps in our knowledge of the role of sex and gender in the onset and progression of Alzheimer’s disease, and these recommendations will provide a useful guide for future research in this area,” Kornstein said in a statement.
The consensus recommendations involve seven themes including: The need to assess the link between sex and Alzheimer’s disease incidence, raise awareness of sex differences among the research community and to take into account sex-based differences in the experimental design and data analysis of studies on disease risk, early diagnosis and drug discovery.
Thirty-six million people worldwide suffer from Alzheimer’s disease and dementia. In Canada, 25,000 new cases are diagnosed each year. Those sobering numbers have researchers around the globe racing to come up with new ways to...
he Food and Drug Administration issued new guides on drug development for neurological disorders. This sets the stage for possible treatments for Alzheimer’s. The disease-oriented development guide documents will provide details on how researchers...
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.